Merz

Type
Business expansion
Country
Germany
Region
Sachsen-Anhalt; Sachsen-Anhalt; Dessau-Roßlau, Kreisfreie Stadt
Location of affected unit(s)
Dessau‑Roßlau
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.20 - Manufacture of pharmaceutical preparations
250 jobs
Number of planned job creations
Job creation
Announcement Date
20 June 2026
Employment effect (start)
20 June 2026
Foreseen end date
31 December 2028

Description

Merz, a German pharmaceutical company, announced the opening of a new packaging centre for its botulinum toxin product in Dessau‑Roßlau in June 2026. The company plans to create up to 250 jobs as part of a €100 million investment, with completion scheduled for 2028.

The expansion is driven by strong growth in international markets and the need to meet rising global demand for both cosmetic and neurological applications of botulinum toxin. All production activities are now consolidated in Dessau‑Roßlau.

Merz employs around 5,500 people worldwide, 450 of whom are employed in Dessau‑Roßlau.

Citation

Eurofound (2026), Merz , Business expansion in Germany, factsheet number 300607, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/300607.